Taiwan · Delayed Price · Currency is TWD Abnova (Taiwan) Company Description
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies.
The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations.
It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.
In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services.
It serves academic, research institutions, and pharmaceutical factories. The company was founded in 2002 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Peiru Ji |
Contact Details
Address: No. 108, Jhouzih Street Taipei, 114 Taiwan | |
| Phone | 886 2 8751 1888 |
| Website | abnova.com |
Stock Details
| Ticker Symbol | 4133 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004133004 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peiru Ji | GM and Director |
| Yaping Zhang | Accounting Supervisor |
| Yi Huang Huang | Deputy General Manager |